HDFC Pharma and Healthcare Fund
Empty
1–7 yearsInvestment Horizon
Empty
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation20.0%
Sharpe Ratio1.03
Beta1.02
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices12.25%
Divi's Laboratories LtdServices10.24%
Cipla LtdServices7.00%
Lupin LtdServices5.59%
Max Healthcare Institute Ltd Ordinary SharesServices4.83%
Glenmark Pharmaceuticals LtdServices4.12%
Ipca Laboratories LtdServices3.99%
Krishna Institute of Medical Sciences LtdServices3.95%
Aster DM Healthcare Ltd Ordinary SharesServices3.92%
Eris Lifesciences Ltd Registered ShsServices3.54%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.02%
Exit Load1
Regulatory & Tax Information
INF179KC1HL7
ISINDailyDealing Frequency
BSE Healthcare PRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)